BATE KENNETH

MDGL

BATE KENNETH serves as Director at Madrigal Pharmaceuticals, Inc. (MDGL). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

4 trades

$27.02M

Net Position

Net Seller

$27.02M

Companies Traded

MDGL

Active Period

Apr 2024 – Nov 2025

4 total trades

Most Recent

Sell MDGL

Nov 5, 2025 · $8.03M

BATE KENNETH's Insider Trading at Madrigal Pharmaceuticals, Inc. (MDGL)

Buys

0 · $0.00

Sells

4 · $27.02M

Total Shares Bought

Total Shares Sold

79,064

MDGL Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Nov 5, 2025	Sell	16,575	$484.30	$8.03M	0
Aug 15, 2025	Sell	10,000	$365.20	$3.65M	0
Feb 27, 2025	Sell	20,000	$356.44	$7.13M	0
Apr 3, 2024	Sell	32,489	$252.85	$8.21M	15,777

Related Insiders

David Soergel

officer: Chief Medical Officer

MDGLSell · Jun 1, 2026

Richard S Levy

director

MDGLSell · May 22, 2026

Shannon T Kelley

officer: General Counsel

MDGLSell · Mar 6, 2026

William John Sibold

President and CEO

MDGLSell · Mar 6, 2026

Rebecca Taub

Director

MDGLSell · Mar 6, 2026

Carole Huntsman

officer: Chief Commercial Officer

MDGLSell · Mar 6, 2026

Mardi Dier

officer: EVP and CFO

MDGLSell · Mar 6, 2026

FRIEDMAN PAUL A

Director

MDGLSell · Jan 13, 2026

Explore More Insider Trading Data

MDGL Insider Trading Activity

View all insider trades at Madrigal Pharmaceuticals, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity